Giles Mark T 4
4 · Diffusion Pharmaceuticals Inc. · Filed Jul 19, 2019
Insider Transaction Report
Form 4
Giles Mark T
Director
Transactions
- Award
Stock Option (Right to Buy)
2019-06-13+13,100→ 13,100 totalExercise: $3.15Exp: 2029-06-13→ Common Stock (13,100 underlying)
Holdings
- 294(indirect: By IRA)
Common Stock
- 53,513(indirect: By LLC)
Common Stock
Footnotes (1)
- [F1]The shares underlying the options vest in 12 equal (or as nearly equal as possible) monthly installments on the last calendar day of each month over a one-year period beginning on June 13, 2019.